Skip to main content
logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
21.64
-0.79 (-3.52%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Arcus Biosciences Revenue

In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%. Arcus Biosciences had revenue of $33.00M in the quarter ending December 31, 2025, with 26.92% growth.

Revenue (ttm)
$247.00M
Revenue Growth
-4.26%
P/S Ratio
10.98
Revenue / Employee
$410,982
Employees
601
Market Cap
2.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals803.79M
Catalyst Pharmaceuticals588.99M
Travere Therapeutics490.73M
Tarsus Pharmaceuticals451.36M
Arcutis Biotherapeutics376.07M
IDEAYA Biosciences218.71M
Beam Therapeutics139.74M
Viridian Therapeutics70.85M
Revenue Rankings

RCUS News

More News